Alexandria Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-43
| Closed | -$6K | – | 568 |
|
|
2017
Q3 | $6K | Buy |
43
+37
| +617% | +$5.16K | ﹤0.01% | 449 |
|
|
2017
Q2 | $1K | Sell |
6
-10
| -63% | -$1.67K | ﹤0.01% | 600 |
|
|
2017
Q1 | $2K | Sell |
16
-13
| -45% | -$1.63K | ﹤0.01% | 564 |
|
|
2016
Q4 | $4K | Sell |
29
-59
| -67% | -$8.14K | ﹤0.01% | 506 |
|
|
2016
Q3 | $11K | Hold |
88
| – | – | ﹤0.01% | 412 |
|
|
2016
Q2 | $10K | Buy |
88
+1
| +1% | +$114 | ﹤0.01% | 415 |
|
|
2016
Q1 | $12K | Buy |
87
+2
| +2% | +$276 | ﹤0.01% | 400 |
|
|
2015
Q4 | $16K | Buy |
85
+2
| +2% | +$376 | ﹤0.01% | 395 |
|
|
2015
Q3 | $13K | Buy |
83
+4
| +5% | +$627 | ﹤0.01% | 379 |
|
|
2015
Q2 | $14K | Buy |
79
+5
| +7% | +$886 | ﹤0.01% | 383 |
|
|
2015
Q1 | $13K | Buy |
74
+4
| +6% | +$703 | ﹤0.01% | 364 |
|
|
2014
Q4 | $13K | Hold |
70
| – | – | 0.01% | 336 |
|
|
2014
Q3 | $12K | Buy |
70
+3
| +4% | +$514 | 0.01% | 330 |
|
|
2014
Q2 | $10K | Sell |
67
-3
| -4% | -$448 | ﹤0.01% | 359 |
|
|
2014
Q1 | $11K | Sell |
70
-12
| -15% | -$1.89K | ﹤0.01% | 354 |
|
|
2013
Q4 | $11K | Buy |
82
+4
| +5% | +$537 | ﹤0.01% | 354 |
|
|
2013
Q3 | $9K | Sell |
78
-7
| -8% | -$808 | ﹤0.01% | 379 |
|
|
2013
Q2 | $8K | Buy |
+85
| New | +$8K | ﹤0.01% | 420 |
|